Phase IIa Study of Flonoltinib Maleate Tablets in the Treatment of Patients With Polycythemia Vera
A phase 2 trial of Flonoltinib 75mg in myeloproliferative neoplasms, run by Chengdu Zenitar Biomedical Technology Co., Ltd, now recruiting.
Overview
Phase IIa Study of Flonoltinib Maleate Tablets in the Treatment of Patients With Polycythemia Vera is a phase 2 interventional study registered as NCT07232290 by Chengdu Zenitar Biomedical Technology Co., Ltd, with 60 participants planned, started 2025-09-23 and due to reach its primary completion in 2027-07-30. Interventions recorded: Flonoltinib 75mg, Flonoltinib 100mg, Flonoltinib 125mg and Extended Phase Dose Group.
Similar pages
not linked directly; found by shared links- TrialStudy of Purinostat Mesylate for Injection in the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL)
Shares Chengdu Zenitar Biomedical Technology and the tag pipeline.
- TrialA Clinical Study of Purinostat Mesylate for Injection in Patients With Advanced Solid Tumors
Shares Chengdu Zenitar Biomedical Technology and the tag pipeline.
- TrialPurinostat Mesylate Combined With Pomalidomide Capsules and Low-dose Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
Shares Chengdu Zenitar Biomedical Technology and the tag pipeline.
- TrialA Phase IIa Clinical Study of Purinostat Mesylate for Injection in Patients With Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma
Shares Chengdu Zenitar Biomedical Technology and the tag pipeline.
- TrialStudy to Assess SLN124 in Patients With Polycythemia Vera
Shares Myeloproliferative neoplasms (PV, ET, myelofibrosis) and the tag pipeline.
- TrialA Phase 2, Open-Label Study of DISC-3405 in Participants With Polycythemia Vera (PV)
Shares Myeloproliferative neoplasms (PV, ET, myelofibrosis) and the tag pipeline.
- TrialStudy of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
Shares Myeloproliferative neoplasms (PV, ET, myelofibrosis) and the tag pipeline.
- TrialA Study of LY2784544 in Participants With Myeloproliferative Neoplasms
Shares Myeloproliferative neoplasms (PV, ET, myelofibrosis) and the tag pipeline.